Evidence map›Paper›PMID 42471830›Full record

ArticleGynecologic oncology reports2026

Low-grade serous carcinoma metastasizing to the chest wall and incidental Müllerian inclusion in a retrosternal lymph node 16 years after the initial ovarian serous borderline tumor: a case report.

Yu Miyama, Haruka Omori, Kousuke Uranishi, Masataka Hirasaki, Tomonori Kawasaki, Akira Yabuno, Tomoaki Torigoe, Hiroyuki Nitanda, Yoshinao Kikuchi, Yuko Sasajima and 2 more

Abstract readCase Reports
In one paragraph

Article in Gynecologic oncology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yu MiyamaDepartment of Pathology, Saitama Medical University International Medical Center, Japan.
Haruka OmoriDepartment of Pathology, Saitama Medical University International Medical Center, Japan.
Kousuke UranishiDivision of Biomedical Sciences, Research Center for Genomic Medicine, Saitama Medical University, Japan.
Masataka HirasakiDivision of Biomedical Sciences, Research Center for Genomic Medicine, Saitama Medical University, Japan.
Tomonori KawasakiDepartment of Pathology, Saitama Medical University International Medical Center, Japan.
Akira YabunoDepartment of Gynecological Oncology, Saitama Medical University International Medical Center, Japan.
Tomoaki TorigoeDepartment of Orthopaedic Oncology & Surgery, Saitama Medical University International Medical Center, Japan.
Hiroyuki NitandaDepartment of General Thoracic Surgery, Saitama Medical University International Medical Center, Japan.
Yoshinao KikuchiDepartment of Pathology, Teikyo University School of Medicine, Tokyo, Japan.
Yuko SasajimaDepartment of Clinical Pathology, Teikyo University School of Medicine, Tokyo, Japan.
Masanori YasudaDepartment of Pathology, Saitama Medical University International Medical Center, Japan.
Taku HommaDepartment of Pathology, Saitama Medical University International Medical Center, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Ovarian serous borderline tumors (SBTs) generally exhibit indolent behavior; however, a small subset of SBTs progresses to low-grade serous carcinoma (LGSC), in some cases after prolonged follow-up. Notably, very late progression with distant metastasis has rarely been reported. Case presentation: A 50-year-old woman with a history of bilateral ovarian SBTs presented with a chest wall mass 16 years after initial diagnosis. At 34 years of age, the initial left ovarian tumor was treated with fertility-sparing surgery and pathologically diagnosed as an SBT pT1c3 because of intraoperative capsule rupture and positive ascitic cytology. After 5 years, the contralateral side lesion was resected, and the patient was diagnosed with recurrent SBT. Sixteen years after the initial diagnosis, imaging revealed a calcified mass at the right sixth costochondral junction. Surgical resection revealed papillary to micropapillary carcinoma with destructive invasion consistent with metastatic LGSC. The tumor cells were positive for estrogen receptor, PAX8, and WT-1, with wild-type p53 expression. A nearby lymph node showed micro-metastasis consisting of a few tumor cells. In addition, an incidentally resected retrosternal lymph node was identified as a nodal Müllerian inclusion. Recurrent SBT, LGSC, and a nodal inclusion commonly harbored Conclusion: This case highlights the potential for the very late malignant progression of ovarian SBTs and the need for long-term surveillance. In addition, the unique location of a nodal inclusion and its clonal relationship with LGSC provide further insights into the pathogenesis of ectopic Müllerian tissues.

Indexed as

Endosalpingiosis, chest wall, sternum, ribLow-grade serous carcinomaNodal Müllerian inclusionSerous borderline tumor

Identifiers

PMID42471830
PMCPMC13380180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.